Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Oct 13, 2022

Accession no.
0001209191-22-053535
Filed
Oct 13, 2022, 7:43 AM ET
Trade date
Oct 12, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market purchases total $172.7K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 12, 2022Common StockPPurchaseAcquired+8,000$1.71+$13,640197,839,694Indirect
Oct 12, 2022Common StockPPurchaseAcquired+300$1.71+$513197,839,994Indirect
Oct 12, 2022Common StockPPurchaseAcquired+152$1.72+$260.68197,840,146Indirect
Oct 12, 2022Common StockPPurchaseAcquired+23,775$1.72+$40,893197,863,921Indirect
Oct 12, 2022Common StockPPurchaseAcquired+16,313$1.73+$28,139.93197,880,234Indirect
Oct 12, 2022Common StockPPurchaseAcquired+26,460$1.73+$45,775.8197,906,694Indirect
Oct 12, 2022Common StockPPurchaseAcquired+25,000$1.74+$43,500197,931,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)